Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 03-11-2016 | Practice Area: | Corporate and M&A |
| Deal Title: | Medivir AB Sale of BioPhausia to Karo Pharma | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Medivir AB (publ) (Nasdaq Stockholm) entered into an agreement with Karo Pharma AB (publ) (Nasdaq Stockholm) regarding the sale of Medivir's subsidiary BioPhausia (Nordic Brands) to Karo Pharma. The purchase price was SEK 908 million.
Vinge advised Medivir.
|
||
| Financial Center: | Stockholm | Value: | 100.01-500.00 |
| Advised Party: | Vendor | Law Firm | Vinge |
| Target Company Jurisdiction: | Sweden | Acquiror Jurisdiction: | Sweden |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | Erik Sjoman |
